Synapse - Nature Research

Results (38)

Analysis of KRAS, NRAS, BRAF and PIK3CA mutations in matched primary and metastatic colorectal carcinomas

Meeting Abstract

Vakiani, E.; Janakiraman, M.; Shia, J.; Saltz, L.; Kemeny, N.; Weiser, M.; Solit, D.
Modern Pathology (2011)

Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: How reliable are biopsy samples?

Meeting Abstract

Shia, J.; Stadler, Z.; Weiser, M.; Rentz, M.; Tang, L.; Vakiani, E.; Katabi, N.; Xiong, X.; Guillem, J.; Klimstra, D.
Modern Pathology (2011)

Fulltext@MSK | Save

Discordance between MSI-H histology and DNA mismatch repair (MMR) protein immunohistochemistry (IHC) in colorectal carcinoma of young patients: Frequency and clinical significance

Meeting Abstract

Shia, J.; Sempoux, C.; Tang, L.; Katabi, N.; Vakiani, E.; Guo, M.; Weiser, M.; Stadler, Z.; Klimstra, D.
Modern Pathology (2010)

Fulltext@MSK | Save

Immunohistochemistry (IHC) for DNA mismatch repair (MMR) proteins in colorectal carcinoma: What does scanty staining for MSH6 mean?

Meeting Abstract

Guo, M.; Klimstra, D.; Tang, L.; Vakiani, E.; Katabi, N.; Stadler, Z.; Weiser, M.; Shia, J.
Modern Pathology (2010)

Fulltext@MSK | Save

PCSK1 expression correlates with improved prognosis in colorectal carcinoma

Meeting Abstract

Silvas, E.; Shia, J.; Notterman, D.; Paty, P.; Gerald, W.; Andea, A.
Modern Pathology (2009)

Fulltext@MSK | Save

Prognostic significance of morphologic features in mucinous colorectal carcinomas

Meeting Abstract

Vakiani, E.; Shia, J.; Dhall, D.; Gonen, M.; Hsu, M.; Tang, L.; Minahane, J.; Weiser, M.; Klimstra, D.
Modern Pathology (2008)

Fulltext@MSK | Save

Prognostic relevance of mucin core protein, beta-catenin and p53 expression in mucinous colorectal carcinomas

Meeting Abstract

Vakiani, E.; Shia, J.; Dhall, D.; Tang, L.; Minahane, J.; Weiser, M.; Klimstra, D.
Modern Pathology (2008)

Fulltext@MSK | Save

Immunohistochemistry (IHC) as first-line screening tool for detecting colorectal cancer (CRC) patients at risk for Lynch syndrome: A 2-antibody panel is as predictive as a 4-antibody panel